It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
This therapy may provide the first potential oral treatment for COVID-19, recognizing the global emergency of new SARS-CoV-2 variants
Anti-malaria API facility will be operational in 15-18 months
Nearly 6,000 patients have been treated with the drug since 2017
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
The goal for the project is the identification and optimization of anti-viral compounds.
Ibuprofen and Famotidine tablets approved by FDA
Drug formulations and biologics make impressive gains
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
Subscribe To Our Newsletter & Stay Updated
